XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2025
Aug. 08, 2025
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2025  
Document Transition Report false  
Entity File Number 001-40363  
Entity Registrant Name TRANSCODE THERAPEUTICS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 81-1065054  
Entity Address, Address Line One 6 Liberty Square, #2382  
Entity Address, City or Town Boston  
Entity Address State Or Province MA  
Entity Address, Postal Zip Code 02109  
City Area Code 857  
Local Phone Number 837-3099  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol RNAZ  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   833,683
Entity Central Index Key 0001829635  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Amendment Flag false